Jamak Clinical Research Institute Ltd is categorized under Commercial Medical Research in Chicago, IL and active since 2008.
Jamak Clinical Research Institute Ltd was established in 2008, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Juan C Villamizar at the company’s single location by writing to 6231 North Legett Avenue, Chicago, Illinois IL 60646 or by phoning (773) 572-8998. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Jamak Clinical Research Institute Ltd |
Contact Person: | Juan C Villamizar |
Address: | 6231 North Legett Avenue, Chicago, Illinois 60646 |
Phone Number: | (773) 572-8998 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Jamak Clinical Research Institute Ltd was started in 2008 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Juan C Villamizar for inquiries that concern Jamak Clinical Research Institute Ltd by calling the company number (773) 572-8998, as your correspondence is most welcome. Additionally, the physical location of the single location of Jamak Clinical Research Institute Ltd can be found at the coordinates 41.994283,-87.753045 as well as the street address 6231 North Legett Avenue in Chicago, Illinois 60646.
For its online presence, you may visit Jamak Clinical Research Institute Ltd’s website at and engage with its social media outlets through on Twitter and on Facebook.